{"retracted":false,"update":{"timestamp":1398729600000,"doi":"10.1007/s40256-014-0075-2","type":"correction"},"doi":"10.1007/s40256-013-0062-z","journal":"American Journal of Cardiovascular Drugs","publisher":"Springer Nature","title":"Erratum to: Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice"}
